^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    VENTANA® MET (SP44) RxDx Assay

    Company:
    Roche
    Type:
    FDA Approved (PMA)
    Related tests:

    Details

    Evidence
    News
    The VENTANA MET (SP44) RxDx Assay scores the MET protein based on how many tumor cells are stained and the intensity of the staining. The assay identified patients whose tumors were positive for MET protein overexpression, defined as ≥50% tumor cells demonstrating strong membrane MET staining
    Cancer:
    Non Small Cell Lung Cancer
    Gene:
    MET (MET proto-oncogene, receptor tyrosine kinase)
    Method:
    Immunohistochemistry (IHC)
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    05/14/25
    NSCLC
    MET
    FDA (PMA)